Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
QuintilesIMS
Colorcon
Express Scripts
Mallinckrodt
Medtronic
US Department of Justice
Boehringer Ingelheim

Generated: April 22, 2018

DrugPatentWatch Database Preview

NEMBUTAL Drug Profile

« Back to Dashboard

Which patents cover Nembutal, and when can generic versions of Nembutal launch?

Nembutal is a drug marketed by Oak Pharms and is included in six NDAs.

The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Drug patent expirations by year for NEMBUTAL
Synonyms for NEMBUTAL
(.+/-.))-Pentobarbital
(+-)-5-Ethyl-5-(1-methylbutyl)barbituric acid
(plusmn)-pentobarbital
(RS)-pentobarbital
057P561
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, (+-)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-sec-pentyl-
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-
30849-50-4
5-24-09-00168 (Beilstein Handbook Reference)
5-ethyl-2-hydroxy-5-(1-methylbutyl)pyrimidine-4,6(1H,5H)-dione
5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione
5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-(1-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-(1-methylbutyl)barbituric acid
5-ethyl-5-(1-methylbutyl)hexahydropyrimidine-2,4,6-trione
5-Ethyl-5-(1-methylbutyl)malonylurea
5-ethyl-5-(pentan-2-yl)-1,3-diazinane-2,4,6-trione
5-ethyl-5-(pentan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-(sec-pentyl)barbituric acid
5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione
57-33-0 (mono-hydrochloride salt)
76-74-4
AC1L1IUE
AC1Q2UJM
Aethaminalum
AKOS000277861
AKOS028114301
AN-19152
AN-23902
API0004783
Barbituric acid, 5-ethyl-5-(1-methylbutyl)-
Barbituric acid, 5-ethyl-5-(2-pentyl)-
BBL028072
BDBM50055935
BRD-A44448661-001-01-4
BRN 0087067
BSPBio_003305
C-12883
C07422
CAS-76-74-4
CC-33572
CCG-220564
CCG-39476
CCRIS 7089
CHEBI:7983
CHEMBL448
component of Emesert (Salt/Mix)
component of Synirin (Salt/Mix)
Continal (Salt/Mix)
D00499
D0F0YZ
DB00312
DivK1c_000992
Dorsital
DSSTox_CID_3435
DSSTox_GSID_23435
DSSTox_RID_77026
DTXSID7023435
EC 200-983-8
EINECS 200-983-8
Etaminal
Ethaminal
Ethyl-propylmethylcarbinylbarbituric acid
GTPL5480
HE048877
HE324681
HE387210
HMS2094E21
HMS503G05
HSDB 3151
IDI1_000992
KBio1_000992
KBio2_002266
KBio2_004834
KBio2_007402
KBio3_002807
KBioGR_001008
KBioSS_002267
LS-24385
Mebubarbital
Mebumal
NCGC00096074-01
NCGC00096074-02
Nebralin
Nembutal (TN)
Nembutal (VAN)
Nembutal sodium
Nembutal|||5-Ethyl-5-(sec-pentyl)barbituric acid
Neodorm
Neodorm (new)
Neodorm (VAN)
NINDS_000992
NSC 28708
NSC-28708
NSC-760434
NSC28708
NSC760434
Oprea1_143902
Oprea1_775730
Pentabarbital
Pentabarbitone
pentobarbital
Pentobarbital (USP/INN)
Pentobarbital (VAN)
Pentobarbital [USP:INN:BAN]
Pentobarbital [USP:INN]
Pentobarbital 0.1 mg/ml in Methanol
Pentobarbital 1.0 mg/ml in Methanol
Pentobarbital calcium
pentobarbital methanol solution
PENTOBARBITAL SODIUM
Pentobarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Pentobarbital suppository dosage form
Pentobarbital, European Pharmacopoeia (EP) Reference Standard
Pentobarbital, Monosodium Salt
Pentobarbital, United States Pharmacopeia (USP) Reference Standard
Pentobarbitale
Pentobarbitale [DCIT]
Pentobarbitalum
Pentobarbitalum [INN-Latin]
Pentobarbitone
Pentobarbitone (VAN)
Pentobarbiturate
Pentobarbituric acid
Pharmakon1600-01900006
Phetobarbitone
R-(+)-Pentobarbital
Rivadorm
SBI-0052713.P002
SCHEMBL11114711
SCHEMBL24966
Sedalixir (Salt/Mix)
Sodium pentobarbital
SPBio_002201
Spectrum_001783
SPECTRUM1900006
Spectrum2_001991
Spectrum3_001783
Spectrum4_000574
Spectrum5_001705
STL367899
Tox21_111555
WEXRUCMBJFQVBZ-UHFFFAOYSA-N
WLN: T6VMVMV FHJ FY3&1 F2

US Patents and Regulatory Information for NEMBUTAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms NEMBUTAL pentobarbital ELIXIR;ORAL 083244-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium CAPSULE;ORAL 084093-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Oak Pharms NEMBUTAL pentobarbital sodium SUPPOSITORY;RECTAL 083247-003 Jan 25, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium CAPSULE;ORAL 083245-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Accenture
Chinese Patent Office
Merck
Fuji
Moodys
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.